Science & academia

Person receiving shot in the arm

Cancer vaccine with minimal side effects nearing Phase 3 clinical trials

The vaccine- developed by Dr. Thomas Wagner of U.S.-based Orbis Health Solutions – has already been tested in hundreds of patients with advanced forms of melanoma in Phase 2 clinical trials. The most recent data showed nearly 95% of people given only the vaccine were still alive three years after starting treatment and 64% were still disease-free. Among the most advanced forms of melanoma, disease-free survival after three years for people with stage III disease was 60% in the vaccine-only group, compared to about 39% in the placebo group.

Artist's concept of a solar power satellite in place

First ever space-to-Earth solar power mission succeeds

A landmark test of beaming solar power to Earth from a satellite has concluded successfully after a year-long mission. Led by scientists at the California Institute of Technology, the mission completed all three of its primary experiments to test key technology for such an endeavor. They included a new origami-inspired solar panel structure, different cell designs, and a microwave transmitter.

Happy family

Consumption poverty in the U.S. has fallen 27% since 1980

Between 1980 and 2022, consumption poverty fell from 33.8% to 6.0% even though the official poverty rate indicated a drop by only 1.5 percentage points over that same period. According to researchers from the University of Notre Dame, consumption, which measures what families are able to purchase in terms of food, housing, transportation, and other goods and services, offers a better indicator of economic well-being than income, which can fluctuate for reasons unrelated to well-being.

House in the snow

Leading heat pump manufacturers develop next-generation prototypes to withstand subfreezing weather

The U.S. Department of Energy has announced that four additional heat pump manufacturers successfully produced heat pump prototypes as part of the Residential Cold Climate Heat Pump (CCHP) Technology Challenge. Launched in 2021, this initiative brings together public and private sector stakeholders to address technical challenges and market barriers to adopting next-generation cold-climate heat pumps—a key clean energy technology that can potentially save households $500 a year or more on their utility bills while also slashing harmful carbon emissions.

Molecule of the human hormone glucagon

Australian scientists regenerate diabetics’ damaged cells to produce insulin

For many years, research has focused on identifying novel therapies that stimulate beta-cell growth and function to restore insulin production in type 1 diabetics. Now, researchers at the Baker Heart and Diabetes Institute in Melbourne have brought us a step closer to making this a reality, regenerating damaged pancreatic cells so they can produce insulin and functionally respond to blood glucose levels. The novel therapeutic approach has the potential to become the first disease-modifying treatment for type 1 diabetes.